Shares in Novavax jumped more than 7% after the biotech company said South Korea’s SK bioscience will manufacture the antigen component of its …
Novavax announced a partnership with Takeda Pharmaceutical to sell up to 250 million doses of NVX‑CoV2373, its COVID-19 vaccine candidate, a year in …
Shares in Novavax are surging 15% in early market trading after the biotech company said that early study data of its COVID-19 vaccine …
Shares in Novavax (NVAX) are currently jumping 42% in pre-market trading after the biotech company said that it has been granted $1.6 billion …
COVID-19 has provided opportunity for a number of healthcare companies to take the baton and run with it. One of the names to …
And just like that, Novavax (NVAX) is back in the spotlight. Gaining a whopping 328% since the start of 2020, the healthcare company …
For better or for worse (but mostly for better), COVID-19 has taken Novavax (NVAX) on a very wild ride. Since the first report …
Fears that China’s outbreak of a new “coronavirus” shocked the stock market on Monday, sending the S&P 500 down 1.57% — and slicing …
Novavax (NVAX) shareholders have had a rough 2019, to say the least, as Mr. Market chopped off more than 90% of the company’s …
B.Riley FBR analyst George Zavoico is out today with a bullish note on shares of Novavax (NASDAQ:NVAX), after the clinical-stage vaccine-maker announced last week that 4,600 …
